Speech and Digital Measures in Neuroscience: From Evidence to Everyday Care

*HLTH 2026 - TICKET REQUIRED | Applications approved by the Sponsor

About this Meeting

Join a small, closed-door group of health system, clinical and industry leaders for a candid conversation on where digital measures in neuropsychiatry stand today. You’ll get a first-hand view of the evidence on emerging digital measures. You’ll compare notes with peers on what it really takes to adopt and scale these tools. And you’ll help shape what researchers and industry deliver next.

Key questions:
What can digital measures add? Where do speech, voice and other objective digital measures improve on today’s interview-based assessment, and what is ready for routine use?
What does real-world adoption take? What barriers to health systems face in adopting, funding, and owning digital measures, and what value case gets them over the line?
What evidence earns trust? What validation, regulatory status and cross-population performance do clinicians and systems need before acting on a measure?
How do research and care connect? Can trial and clinical measures converge, and what makes pharma, health system and academic partnerships work?